- Home
- LVLU vs DTIL Comparison
LVLU vs DTIL Comparison
Compare LVLU & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVLU
- DTIL
- Stock Information
- Founded
- LVLU 1996
- DTIL 2006
- Country
- LVLU United States
- DTIL United States
- Employees
- LVLU N/A
- DTIL N/A
- Industry
- LVLU Catalog/Specialty Distribution
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- LVLU Consumer Discretionary
- DTIL Health Care
- Exchange
- LVLU Nasdaq
- DTIL Nasdaq
- Market Cap
- LVLU 47.5M
- DTIL 44.1M
- IPO Year
- LVLU 2021
- DTIL 2019
- Fundamental
- Price
- LVLU $0.89
- DTIL $4.97
- Analyst Decision
- LVLU Hold
- DTIL Strong Buy
- Analyst Count
- LVLU 3
- DTIL 3
- Target Price
- LVLU $1.58
- DTIL $37.67
- AVG Volume (30 Days)
- LVLU 36.4K
- DTIL 1.3M
- Earning Date
- LVLU 03-05-2025
- DTIL 11-04-2024
- Dividend Yield
- LVLU N/A
- DTIL N/A
- EPS Growth
- LVLU N/A
- DTIL N/A
- EPS
- LVLU N/A
- DTIL 1.45
- Revenue
- LVLU $324,699,000.00
- DTIL $75,096,000.00
- Revenue This Year
- LVLU N/A
- DTIL $51.35
- Revenue Next Year
- LVLU $1.72
- DTIL N/A
- P/E Ratio
- LVLU N/A
- DTIL $3.42
- Revenue Growth
- LVLU N/A
- DTIL 43.62
- 52 Week Low
- LVLU $0.89
- DTIL $3.61
- 52 Week High
- LVLU $2.13
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- LVLU 31.13
- DTIL 47.54
- Support Level
- LVLU $0.92
- DTIL $5.10
- Resistance Level
- LVLU $1.03
- DTIL $7.44
- Average True Range (ATR)
- LVLU 0.08
- DTIL 0.67
- MACD
- LVLU -0.01
- DTIL 0.09
- Stochastic Oscillator
- LVLU 0.00
- DTIL 35.51
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.